Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act

Crit Care. 2022 Aug 5;26(1):238. doi: 10.1186/s13054-022-04104-y.

Authors

Timothy Arthur Chandos Snow¹, Antonio Cesar², Mervyn Singer², Nishkantha Arulkumaran²

Affiliations

¹ Bloomsbury Institute of Intensive Care Medicine, University College London, Gower Street, London, WC1E 6DH, UK. timothy.snow@doctors.net.uk.
² Bloomsbury Institute of Intensive Care Medicine, University College London, Gower Street, London, WC1E 6DH, UK.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Clarithromycin* / pharmacology
Clarithromycin* / therapeutic use
Humans
Immunologic Factors / pharmacology
Immunologic Factors / therapeutic use
Multiple Organ Failure / drug therapy
Sepsis* / drug therapy

Substances

Anti-Bacterial Agents
Immunologic Factors
Clarithromycin